Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2017, Article ID 7212713, 7 pages
https://doi.org/10.1155/2017/7212713
Clinical Study

Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial

1Tom Baker Cancer Centre and Division of Palliative Medicine, University of Calgary, 1331 29 Street NW, Calgary, AB, T2N4N2, Canada
2ClinForce Services Inc., Vancouver, BC, Canada
3PRA Health Sciences, Victoria, 655 Tyee Rd., Victoria, BC, Canada V9A 6X5
4Statcon Consulting Services, 6 Matson Drive, Caledon, ON, Canada L7E 0A3
5Département d’Anesthésiologie, CHUM, 1560, rue Sherbrooke Est, Pavillon Deschamps, Local FS-1136, Montréal, QC, Canada H2L 4M1
6St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
7Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, CP 6128 Centre-Ville, Montréal, QC, Canada H3C 3J7
8WEX Pharmaceuticals Inc., 420-1090 West Pender Street, Vancouver, BC, Canada V6E 2N7
9Clinical Research Unit, Jewish General Hospital, Room E-872 3755, Chemin de la Côte Sainte-Catherine, Montréal, QC, Canada H3T 1E2

Correspondence should be addressed to Neil A. Hagen; moc.liamg@5negahlien

Received 15 September 2016; Accepted 23 March 2017; Published 7 May 2017

Academic Editor: Jacob Ablin

Copyright © 2017 Neil A. Hagen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. E. Prommer, “Pharmacological management of cancer-related pain,” Cancer Control, vol. 22, no. 4, pp. 412–425, 2015. View at Google Scholar · View at Scopus
  2. S. H. Ahmedzai, “Cancer pain for the 21st century: stepping off the ladder, stepping up to new challenges,” British Journal of Pain, vol. 8, no. 4, pp. 131–132, 2014. View at Publisher · View at Google Scholar
  3. C. H. Lee and P. C. Ruben, “Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin,” Channels, vol. 2, no. 6, pp. 407–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. G. Moczydlowski, “The molecular mystique of tetrodotoxin,” Toxicon, vol. 63, no. 1, pp. 165–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. “Tetrodotoxin is safe and effective for severe, refractory cancer pain,” The Journal of Supportive Oncology, vol. 2, no. 1, p. 18, 2004.
  6. N. A. Hagen, K. M. Fisher, B. Lapointe et al., “An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain,” Journal of Pain and Symptom Management, vol. 34, no. 2, pp. 171–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. A. Hagen, P. du Souich, B. Lapointe et al., “Tetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter study,” Journal of Pain and Symptom Management, vol. 35, no. 4, pp. 420–429, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. A. Hagen, B. Lapointe, M. Ong-Lam et al., “A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain,” Current Oncology, vol. 18, no. 3, pp. e109–e116, 2011. View at Google Scholar · View at Scopus
  9. D. C. Turk, R. H. Dworkin, R. R. Allen et al., “Core outcome domains for chronic pain clinical trials: IMMPACT recommendations,” Pain, vol. 106, no. 3, pp. 337–345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. N. Jamison and J. Mao, “Opioid analgesics,” Mayo Clinic Proceedings, vol. 90, no. 7, pp. 957–968, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Ballantyne, E. Kalso, and C. Stannard, “WHO analgesic ladder: a good concept gone astray,” British Medical Journal, vol. 352, p. i20, 2016. View at Google Scholar
  12. S. Falk, K. Bannister, and A. H. Dickenson, “Cancer pain physiology,” British Journal of Pain, vol. 8, no. 4, pp. 154–162, 2014. View at Publisher · View at Google Scholar
  13. S. Johnston, “Effectiveness and safety of high-dose opioids for chronic pain,” American Family Physician, vol. 81, no. 6, pp. 693–695, 2010. View at Google Scholar · View at Scopus